Unable to speak because of a brain disorder known as spasmodic dysphonia, Susan O'Sullivan signed up for a clinical trial, ...

An expert has shed light on the signs of a widely prevalent yet often imperceptible condition affecting nearly 8 million ...

A new study using Mendelian randomization suggests that higher copper levels may increase fibromyalgia risk, while iron may ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a prescription pill that’s taken every ...

In the Opportunity Research report, analyst Rob Goldman reviews clinical and preclinical data on OKYO's lead candidate, the Company's inherent first-mover opportunities in the industry, upcoming ...

Accomplished Business and Financial Leader, Laura Brege, Appointed Chair ---- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.